Similar companies
| Company | Revenue | |
|---|---|---|
![]() |
CostcoCOST |
63.2B 0.8% |
Income Statement (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Revenue | 39B | 1% |
| Gross Profit | 6.51B | 6.2% |
| Cost of Revenue | 32.5B | 2.6% |
| Operating expense | 6.45B | 48.4% |
| Net Income | -175M | 93.9% |
| EBITDA | 624M | 117.8% |
Balance Sheet (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Total Assets | 69.4B | 1.2% |
| Total Liabilities | 62.1B | 1.4% |
| Total Equity | 7.18B | 1% |
| Shares Outstanding | 865M | 0.1% |
Cash Flow (USD)
| Q2 '25 | QoQ | |
|---|---|---|
| Cash from operations | 584M | 393.5% |
| Cash from investing | -82M | 119.6% |
| Cash from financing | -812M | 181.9% |
EPS
Financial Highlights for Walgreens in Q2 '25
Walgreens reported a revenue of 39B, which is a 1% change from the previous quarter. An increase in revenue typically indicates growing demand for the company's products or services. This positive change in revenue is a good sign, suggesting that the company's sales are moving in the right direction.
Gross Profit stood at 6.51B, marking a -6.2% change since the last quarter. Gross profit showcases the efficiency in production and sales processes.
Cost of Revenue was 32.5B, a 2.6% difference from the previous quarter. A rising cost of revenue may suggest increased production or sales costs, which can impact margins. However, if accompanied by a proportionate rise in revenue, it could indicate scaling operations.
Operating Expenses for this period were 6.45B, showing a -48.4% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -175M, showing a 93.9% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was 624M, showing a 117.8% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Walgreens faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. An increase in the cost of revenue, higher than the revenue growth, suggests potential margin pressures.
